CardioVascular and Interventional Radiology

, Volume 41, Issue 11, pp 1683–1690 | Cite as

Thrombophilia Associated with Early Post-angioplasty Thrombosis of Dialysis Vascular Access

  • Tsung-Yan Chen
  • Lin Lin
  • Mu-Yang Hsieh
  • Chiu-Hui Chen
  • Meng-Kan Chen
  • Chih-Cheng WuEmail author
Clinical Investigation Venous Interventions
Part of the following topical collections:
  1. Venous Interventions



Percutaneous transluminal angioplasty (PTA) is widely used as the primary treatment for dialysis vascular access dysfunction. Nonetheless, many patients develop early occlusion after angioplasty. Thus, we investigated the role of thrombophilia in access occlusion within 30 days of angioplasty.

Materials and Methods

This case–control study included patients who underwent PTA for dialysis vascular access dysfunction. Patients who experienced occlusion within 30 days of angioplasty were included in the case group and those without occlusion for at least 30 days after angioplasty were included in the control group. All patients were tested for protein C, protein S, antithrombin III, lupus anticoagulant, and anticardiolipin antibodies.


From February to October 2015, 462 patients underwent PTA for dialysis vascular access dysfunction. Forty-one patients (8.9%) had early occlusion within 30 days of angioplasty. The case group had more graft accesses (73 vs. 31%, P < 0.001) and thrombotic occlusions (67 vs. 15%, P < 0.001). A higher incidence of protein C (10 vs. 2%), protein S (15 vs. 5%), and antithrombin III (10 vs. 2%) deficiency and elevated anticardiolipin antibody (22 vs. 10%) levels were observed in the case group. Overall, 26 patients (63%) in the case group had at least one thrombophilic factor, compared with 15 patients (37%) in the control group (unadjusted odds ratio [OR], 3.004; 95% confidence interval [CI], 1.223–7.380; P = 0.027). After adjustment for confounding factors, the association between thrombophilic factors and early occlusion remained (adjusted OR, 3.806; 95% CI, 1.018–14.220; P = 0.047).


Thrombophilia is associated with early occlusion after angioplasty for hemodialysis vascular access.


Thrombophilia Post-angioplasty occlusion Dialysis Vascular access 



We thank the staff of Biotechnology R&D Center, National Taiwan University Hospital, Hsin-Chu Branch for their assistance in statistical analysis and interpretation of results.


This study was funded by National Taiwan University Hospital, Hsinchu Branch (Grant Numbers HCH104-10 and HCH105-7) and by the Ministry of Science and Technology (Grant Number 106-2314-B-002-173-MY3). The funders had no role in the study design, in the collection, analysis or interpretation of data, in writing this report, or in the decision to submit this report for publication.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    National Kidney Foundation. Dialysis outcomes quality initiative: NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 1997;30(4 Suppl 3):S150–91.Google Scholar
  2. 2.
    Neuen BL, Gunnarsson R, Baer RA, Tosenovsky P, Green SJ, Golledge J, et al. Factors associated with patency following angioplasty of hemodialysis fistulae. J Vasc Interv Radiol. 2014;25(9):1419–26.CrossRefGoogle Scholar
  3. 3.
    Lilly RZ, Carlton D, Barker J, Saddekni S, Hamrick K, Oser R, et al. Predictors of arteriovenous graft patency after radiologic intervention in hemodialysis patients. Am J Kidney Dis. 2001;37(5):945–53.CrossRefGoogle Scholar
  4. 4.
    Schwab SJ, Oliver MJ, Suhocki P, McCann R. Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow. Kidney Int. 2001;59(1):358–62.CrossRefGoogle Scholar
  5. 5.
    Sarkar O, Assadian A, Frank H, Moessmer G, Heemann U, Eckstein HH. Hereditary and acquired thrombophilic disorders complicating vascular access in haemodialysis: O. Sarkar et al. NDT Plus. 2010;3(4):393–6.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Knoll GA, Wells PS, Young D, Perkins SL, Pilkey RM, Clinch JJ, et al. Thrombophilia and the risk for hemodialysis vascular access thrombosis. J Am Soc Nephrol. 2005;16(4):1108–14.CrossRefGoogle Scholar
  7. 7.
    Manns BJ, Burgess ED, Parsons HG, Schaefer JP, Hyndman ME, Scott-Douglas NW. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int. 1999;55(1):315–20.CrossRefGoogle Scholar
  8. 8.
    Nampoory MR, Das KC, Johny KV, Al-Hilali N, Abraham M, Easow S, et al. Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation. Am J Kidney Dis. 2003;42(4):797–805.CrossRefGoogle Scholar
  9. 9.
    O’Shea SI, Lawson JH, Reddan D, Murphy M, Ortel TL. Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg. 2003;38(3):541–8.CrossRefGoogle Scholar
  10. 10.
    Wu CC, Wen SC, Chen MK, Yang CW, Pu SY, Tsai KC, et al. Radial artery approach for endovascular salvage of occluded autogenous radial-cephalic fistulae. Nephrol Dial Transplant. 2009;24(8):2497–502.CrossRefGoogle Scholar
  11. 11.
    Wu CC, Lin MC, Pu SY, Tsai KC, Wen SC. Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol. 2008;19(6):877–83.CrossRefGoogle Scholar
  12. 12.
    Wu CC, Hsieh MY, Hung SC, Kuo KL, Tsai TH, Lai CL, et al. Serum indoxyl sulfate associates with postangioplasty thrombosis of dialysis grafts. J Am Soc Nephrol. 2016;27(4):1254–64.CrossRefGoogle Scholar
  13. 13.
    Hsieh MY, Chen TY, Lin L, Chuang SY, Lin SJ, Tarng DC, et al. Deficiency of circulating progenitor cells associated with vascular thrombosis of hemodialysis patients. Nephrol Dial Transplant. 2017;32(3):556–64.CrossRefGoogle Scholar
  14. 14.
    Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol. 2002;22(11):1769–76.CrossRefGoogle Scholar
  15. 15.
    Otsuka F, Finn AV, Yazdani SK, Nakano M, Kolodgie FD, Virmani R. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol. 2012;9(8):439–53.CrossRefGoogle Scholar
  16. 16.
    Padfield GJ, Newby DE, Mills NL. Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol. 2010;55(15):1553–65.CrossRefGoogle Scholar
  17. 17.
    Zavalloni D, Presbitero P, Lodigiani C, Mango R, Cogliati T, Quaglia I, et al. Prevalence of inherited thrombophilia in patients with documented stent thrombosis. Circ J. 2012;76(8):1874–9.CrossRefGoogle Scholar
  18. 18.
    Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146(6):948–57.CrossRefGoogle Scholar
  19. 19.
    Adler S, Szczech L, Qureshi A, Bollu R, Thomas-John R. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis. Clin Nephrol. 2001;56(6):428–34.PubMedGoogle Scholar
  20. 20.
    Chuang FR, Chang HW, Lin CL, Wang IK, Chang HY, Wang PH, et al. Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis. Int J Clin Pract. 2005;59(7):785–90.CrossRefGoogle Scholar
  21. 21.
    Cockwell P, Tse WY, Savage CO. Activation of endothelial cells in thrombosis and vasculitis. Scand J Rheumatol. 1997;26(3):145–50.CrossRefGoogle Scholar
  22. 22.
    Prakash R, Miller CC 3rd, Suki WN. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis. 1995;26(2):347–52.CrossRefGoogle Scholar
  23. 23.
    Crowther MA, Clase CM, Margetts PJ, Julian J, Lambert K, Sneath D, et al. Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial. J Am Soc Nephrol. 2002;13(9):2331–7.CrossRefGoogle Scholar
  24. 24.
    Kaufman JS, O’Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol. 2003;14(9):2313–21.CrossRefGoogle Scholar
  25. 25.
    Lee PC, Lee PH, Shaw CK, Lei HY, Chen JC, Takemoto S. Effectiveness of an organ-sharing program in providing zero HLA-A, B, DR mismatched kidneys for transplantation in Taiwan. J Formos Med Assoc. 2000;99(6):447–52.PubMedGoogle Scholar
  26. 26.
    Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb Res. 1997;87(4):377–85.CrossRefGoogle Scholar
  27. 27.
    Liu HW, Kwong YL, Bourke C, Lam CK, Lie AK, Wei D, et al. High incidence of thrombophilia detected in Chinese patients with venous thrombosis. Thromb Haemost. 1994;71(4):416–9.PubMedGoogle Scholar
  28. 28.
    Rabes JP, Trossaert M, Conard J, Samama M, Giraudet P, Boileau C. Single point mutation at Arg506 of factor V associated with APC resistance and venous thromboembolism: improved detection by PCR-mediated site-directed mutagenesis. Thromb Haemost. 1995;74(5):1379–80.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2018

Authors and Affiliations

  1. 1.Cardiovascular CenterNational Taiwan University Hospital, Hsinchu BranchHsinchu CityTaiwan
  2. 2.College of MedicineNational Taiwan UniversityTaipeiTaiwan
  3. 3.Hemodialysis CenterNational Taiwan University Hospital, Hsinchu BranchHsinchuTaiwan
  4. 4.Department of Family MedicineNational Taiwan University Hospital, Hsinchu BranchHsinchuTaiwan
  5. 5.Institute of Biomedical EngineeringNational Tsing-Hua UniversityHsinchuTaiwan

Personalised recommendations